Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mudan Granule for Type 2 Diabetic Peripheral Neuropathy
NCT04711980Phase 1Unknown
- Start
- Jun 2021
- Primary completion
- Feb 2022
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in diabetic peripheral neuropathy (DPN) comparing Mudan granule with Placebo (2 arms). Primary endpoint: Michigan Diabetic Neuropathy Score at 24 weeks. Status: unknown.
02
Drugs
Mudan Granules
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04711980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711980.